IGC Pharma, Inc. (IGC)
0.3416
+0.01
(+4.18%)
USD |
NYAM |
Dec 12, 16:00
0.3416
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Research and Development Expense (Annual): 3.655M for March 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Esperion Therapeutics, Inc. | 46.24M |
| Theravance Biopharma, Inc. | 36.04M |
| NRX Pharmaceuticals, Inc. | 6.199M |
| CEL-SCI Corp. | 18.16M |
| AIM ImmunoTech, Inc. | 6.149M |